Business

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

The cannabis pharmaceuticals market is poised for significant growth due to rising medical cannabis legalization, increasing R&D investment, and demand for alternative treatments. Key opportunities include advancements in cannabinoid research, therapeutic applications in chronic pain, neurological disorders, and mental health conditions, and the development of cannabis-based formulations driven by regulatory approvals and evolving healthcare systems. Cannabis Pharmaceuticals Market Cannabis Phar

articleAbbvie Inc.May 18, 20266/company/abbvie-inc/news/cannabis-pharmaceuticals-business-research-report-2026-an-dollar1111-billion-market-by-2032-from-dollar47-billion-in-2025-featuring-abbvie-aphria-aurora-cannabis-bausch-health-and-canopy-growth
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

About this update from Abbvie Inc.

[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The cannabis pharmaceuticals market is poised for significant growth due to rising medical cannabis legalization, increasing R&D investment, and demand for alternative treatments. Key opportunities include advancements in cannabinoid research, therapeutic applications in chronic pain, neurological disorders, and mental health conditions, and the development of cannabis-based formulations driven by regulatory approvals and evolving healthcare systems.","length":458,"tagName":"p"},{"type":"text","content":"Cannabis Pharmaceuticals Market","length":31,"tagName":"p"},{"type":"image","alt":"Cannabis Pharmaceuticals Market","displaySize":"","headline":null,"caption":"Cannabis Pharmaceuticals Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/6436d370a59f67885aa1661c208e0562"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0kyNQ8D1UibebK2IrD0krA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/6436d370a59f67885aa1661c208e0562","width":600,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/y28Kv1Ze_.8NZJB3AIzOUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://media.zenfs.com/en/globenewswire.com/6436d370a59f67885aa1661c208e0562","width":600,"height":400}}},{"type":"text","content":"Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Cannabis Pharmaceuticals - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Cannabis Pharmaceuticals was estimated at US$4.7 Billion in 2025 ...

More updates from Abbvie Inc.

Pharmaceuticalsmedical cannabiscannabis legalizationCanopy Growth Corporationglobal marketAurora Cannabisglobal healthcare industryalternative treatmentsPharmaceuticalsMarket GrowthMarket Value